| Bill | HR 4538 |
|---|---|
| Type of Legislation | House Bill |
| Congress | 116 |
| Source | View original on Congress.gov |
Geographic Scope
National
Description
Closing Loopholes for Orphan Drugs Act
This bill amends the Public Health Service Act to revise the 340B Drug Pricing Program, which currently requires drug manufacturers to discount orphan drugs (i.e., drugs for rare conditions) for certain entities covered by the program. The bill discounts orphan drugs that are not being used to treat rare conditions for all entities covered by the program.
Bill Title
Closing Loopholes for Orphan Drugs Act
Linked Goals
Steps
- 2019-09-26: Referred to the House Committee on Energy and Commerce.
- 2019-09-26: Introduced in House
- 2019-09-26: Introduced in House
- 2019-09-27: Referred to the Subcommittee on Health.
Projected Outcome
A more informed proposal or public response aligned with the Promote General Welfare goal.